Stay updated with breaking news from Cell Engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In proof-of-concept experiments, Johns Hopkins Medicine scientists say they have successfully cultivated human muscle stem cells capable of renewing themselves and repairing muscle tissue damage in mice, potentially advancing efforts to treat muscle injuries and muscle-wasting disorders in people.
In proof-of-concept experiments, Johns Hopkins Medicine scientists say they have successfully cultivated human muscle stem cells capable of renewing themselves and repairing muscle tissue damage in mice, potentially advancing efforts to treat muscle
HORIBA UK partners with academia to develop new methods for drug discovery and disease diagnosis.
Type-1 diabetes (T1D) is a chronic metabolic autoimmune disease where the patient's immune system destroys insulin-producing β-cells in the islet of Langerhans. The current treatment option is through frequent administration of exogenous insulin, where the patients must closely monitor the dosage. Patients often need islet transplantation when the β-cell destruction worsens, and the body cannot utilize exogenously administrated insulin. Islet transplantation is a form of cell therapy that could restore endogenous insulin production. However, this method has several drawbacks, including ...
MiGenTra appoints with Heidi Hunter, Petra Reinke and Shaheer Bardissi three highly distinguished international leaders in Science and Entrepreneurship to its Advisory Board.